New macrolide, lincosaminide and streptogramin B antibiotics

Abstract

Importance of the field: New antibiotics are needed to overcome microbial resistance and to improve on the therapeutic index and clinical effectiveness of existing agents.

Area covered in this review: This review covers the journal and patent literature published from about the mid-2000s to 2010 to provide an overview of the large diversity of new chemical entities in the macrolide, lincosaminide and streptogramin B (MLS_B) class.

What the reader will gain: The review identifies areas of the greatest effort and recent results in pursuing structure–activity relationships among MLS_B antibiotics and highlights preclinical and clinical candidates that have arisen from these diverse discovery programs.

Take home message: Research on the MLS_B class appears promising for the eventual registration and commercialization of several new antibiotics that improve the clinical effectiveness of existing agents and combat antibiotic-resistant pathogens.

Keywords::

• antibiotic
• erythromycin
• ketolide
• lincosaminide
• macrolide
• MLS_B class
• streptogramin

Notes

This box summarizes key points contained in the article.